Rare diseases
Investigational molecules
Locations
Phase 1/2 Study of CR-001 Safety and Dose Finding in Adults with Locally Advanced or Metastatic Solid Tumors
ItalyEvaluation of NXT007 versus Emicizumab Prophylaxis in Patients with Hemophilia A
ItalyA Phase III study of NXT007 compared with simoctocog alfa prophylaxis in patients with Hemophilia A without inhibitors
ItalyStudy of pelabresib (DAK539) plus ruxolitinib versus placebo plus ruxolitinib in adult patients with myelofibrosis who are JAK‑inhibitor‑naive
ItalyDurvalumab and Chemotherapy in Adults With Muscle-Invasive Bladder Cancer
ItalyNHS7108 for Exocrine Pancreatic Insufficiency in Adult Patients
ItalyQTX-2101 and Arsenic Trioxide in Adult Patients With Acute Promyelocytic Leukemia
ItalyObrixtamig, Carboplatin, and Etoposide for First-Line Treatment of Advanced Extrapulmonary Neuroendocrine Carcinoma in DLL3-Positive Patients
ItalyA Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer
ItalyCenegermin Eye Drops for Persistent Corneal Epithelial Defect in Patients with Persistent Corneal Epithelial Defect
ItalyFWY003 in Geographic Atrophy Secondary to Age-Related Macular Degeneration in Patients
ItalyBelzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
